{"id":"nbp608-mid-potency","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin atrophy"},{"rate":null,"effect":"Telangiectasia"},{"rate":null,"effect":"Striae"},{"rate":null,"effect":"Local irritation or burning"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"As a mid-potency topical or systemic corticosteroid, NBP608 works by activating glucocorticoid receptors in immune cells and inflamed tissues, leading to decreased production of pro-inflammatory cytokines and reduced recruitment of immune cells. This mechanism makes it suitable for treating inflammatory and allergic conditions where moderate anti-inflammatory potency is desired.","oneSentence":"NBP608 is a mid-potency corticosteroid that reduces inflammation by binding to glucocorticoid receptors and suppressing immune and inflammatory responses.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:22:50.170Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory skin conditions (dermatitis, eczema, psoriasis)"},{"name":"Allergic and inflammatory disorders"}]},"trialDetails":[{"nctId":"NCT07415252","phase":"PHASE3","title":"SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years","status":"NOT_YET_RECRUITING","sponsor":"SK Bioscience Co., Ltd.","startDate":"2026-06-05","conditions":"Varicella (Chickenpox)","enrollment":780},{"nctId":"NCT03121638","phase":"PHASE1","title":"Safety Study of NBP608 in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2012-11","conditions":"Varicella Zoster, Immunization; Infection","enrollment":150},{"nctId":"NCT03114982","phase":"PHASE2","title":"The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2016-05","conditions":"Varicella","enrollment":152}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"NBP608 (Mid Potency)","genericName":"NBP608 (Mid Potency)","companyName":"SK Bioscience Co., Ltd.","companyId":"sk-bioscience-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"NBP608 is a mid-potency corticosteroid that reduces inflammation by binding to glucocorticoid receptors and suppressing immune and inflammatory responses. Used for Inflammatory skin conditions (dermatitis, eczema, psoriasis), Allergic and inflammatory disorders.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}